Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Western Uranium & Vanadium (WSTRF) Common Equity (2016 - 2025)

Western Uranium & Vanadium (WSTRF) has disclosed Common Equity for 8 consecutive years, with $27.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 3.0% to $27.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $27.9 million, a 3.0% decrease, with the full-year FY2024 number at $29.8 million, down 3.1% from a year prior.
  • Common Equity was $27.9 million for Q3 2025 at Western Uranium & Vanadium, down from $28.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $33.3 million in Q1 2024 to a low of $22.4 million in Q1 2021.
  • A 5-year average of $27.8 million and a median of $28.4 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 30.94% in 2022, then fell 17.54% in 2025.
  • Western Uranium & Vanadium's Common Equity stood at $23.1 million in 2021, then grew by 26.67% to $29.3 million in 2022, then grew by 5.17% to $30.8 million in 2023, then dropped by 3.1% to $29.8 million in 2024, then fell by 6.46% to $27.9 million in 2025.
  • Per Business Quant, the three most recent readings for WSTRF's Common Equity are $27.9 million (Q3 2025), $28.9 million (Q2 2025), and $27.4 million (Q1 2025).